Nanopath

company

About

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$10M
Industries
Biotechnology
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$10.25M
Nanopath has raised a total of $10.25M in funding over 2 rounds. Their latest funding was raised on Aug 9, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 9, 2022 Series A $10M 1 Norwest Venture Partners Detail
Dec 21, 2021 Grant $255.87K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Nanopath is funded by 2 investors. Norwest Venture Partners and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Yes Series A
National Science Foundation Yes Grant